A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery

Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures. Touch Surgery™ Aide will be shared at the Society of Robotic Surgery (SRS) 2026 Annual Meeting in Florida, July 23-26.

Built on years of experience, the Touch Surgery™ ecosystem brings insight to surgery, in more than 1,500 operating rooms worldwide. It connects the entire surgical journey: bridging pre-operative planning and training, intra-operative tele-mentoring and tele-proctoring, and AI-powered post-operative insight, simplifying workflows and extending access beyond individual ORs.

Touch Surgery™ Aide expands the Touch Surgery™ ecosystem with next-generation computing capabilities, enabling multimodal AI-driven support during surgery. This provides surgeons with access to actionable insights during procedures, supports case review, and helps inform continuous improvement in clinical decision-making.

"Real-time AI marks a new frontier for healthcare — it is a fundamental evolution in how surgery is supported, moving from technology that assists the surgeon's hand to technology that helps teams work smarter, move faster, and deliver greater impact in the moment," said Jim Peichel, Chief Technology Officer at Medtronic.

Touch Surgery™ Aide incorporates NVIDIA's accelerated computing infrastructure, leveraging the company's Holoscan, CUDA, and TensorRT to deliver AI-powered insights in the moment, supporting surgical decision-making when it matters most. Touch Surgery™ Aide combines computer vision, multimodal AI, and accelerated inference to process surgical video and procedural context in real time. This enables multiple AI applications to run simultaneously during a live procedure, processing and acting on surgical data in the moment. It brings intelligent, increasingly automated support in the OR, and is designed to continuously learn and evolve. 

Medtronic's first real-time AI application for robotic surgery
Instrument Exit Point (IEP) is an AI application that runs on Touch Surgery™ Aide, for use with the Hugo™ robotic-assisted surgery (RAS) system. It received U.S. Food and Drug Administration (FDA) clearance.

Using computer vision, IEP provides a visual notification when select instruments move beyond the visible field of view during a robotic procedure. As the first real-time AI application to run on Touch Surgery™ Aide, IEP represents an early step in bringing AI-enabled support into robotic surgery, with the platform designed to support expansion into laparoscopic surgery over time.

Medtronic continues to progress the capabilities of the Hugo™ robotic-assisted surgery (RAS) system. In December 2025, the Hugo™ RAS system received FDA clearance for use in urologic surgical procedures, bringing a versatile robotic-assisted platform to U.S. surgeons and health systems. In June 2026, Medtronic announced 510(k) submissions to expand the use of the Hugo™ RAS system into general and gynecologic specialties in the U.S. The Hugo™ RAS system continues to have a growing global impact and has been used in tens of thousands of procedures across more than 35 countries in six continents. 

Transforming the future of surgery
This is an early step in a broader effort to bring AI into more of what happens in the operating room. Over time, Medtronic expects the platform to support a growing range of real-time AI applications, connect with other Medtronic technologies in the OR, and turn the data from every case into insight for surgical teams and the hospitals they work in.

"Surgery is on the cusp of a generational shift, powered by AI and advanced compute," said George Murgatroyd, General Manager & Vice President, Digital Technologies within the Surgical business at Medtronic. "The Touch Surgery™ ecosystem, powered by Touch Surgery™ Aide, establishes a platform for a new generation of embedded connectivity, seamlessly integrating advanced capabilities into surgical workflows and reinforcing Medtronic's commitment to delivering the best possible care, for every patient, anywhere."

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:


Gary Jeanfaivre      

Ingrid Goldberg

Public Relations

Investor Relations

+1-203-556-0777

+1-763-505-2696

Touch Surgery(TM) Aide and the Touch Surgery(TM) ecosystem

Hugo(TM) Robotic Assisted Surgery system console and Touch Surgery(TM) ecosystem with the next-generation compute platform Touch Surgery(TM) Aide

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/a-new-era-for-surgery-with-real-time-ai-medtronic-to-unveil-touch-surgery-aide-the-next-generation-compute-platform-for-the-operating-room-at-society-of-robotic-surgery-2026-302830108.html

SOURCE Medtronic plc

News Provided by PR Newswire via QuoteMedia

MDT
The Conversation (0)
Red Mountain Mining

Acquisition of “Thompson Falls” High-Grade Antimony Project Adjacent to America’s only Antimony Smelter

Red Mountain Mining Limited (ASX: RMX, US CODE: RMXFF, or “Company”), a Critical Minerals exploration and development company with an established portfolio in Tier-1 Mining Districts in the United States and Australia, is pleased to announce the Company’s newly-acquired Thompson Falls Antimony... Keep Reading...
New Found Gold Announces Participation in Upcoming Mining Conferences, Including Precious Metals Summit and Mining Forum Americas 2025

New Found Gold Announces Participation in Upcoming Mining Conferences, Including Precious Metals Summit and Mining Forum Americas 2025

New Found Gold Corp. (" New Found Gold " or the " Company ") (TSXV: NFG) (NYSE-A: NFGC) is pleased to announce the Company will be participating in several upcoming conferences, including the Precious Metals Summit and Mining Forum Americas 2025. The focus of these conferences will be to discuss... Keep Reading...
Pine Cliff Energy Ltd. Announces First Quarter 2024 Results and Information Regarding the Annual Meeting of Shareholders

Pine Cliff Energy Ltd. Announces First Quarter 2024 Results and Information Regarding the Annual Meeting of Shareholders

Pine Cliff Energy Ltd. (TSX: PNE) ("Pine Cliff" or the "Company") announces its first quarter 2024 financial and operating results, an operational update and information regarding the annual meeting of shareholders. First Quarter 2024 Results Results for the three months ended March 31, 2024 are... Keep Reading...

Canadian Natural Resources Limited Announces 2024 First Quarter Results

Canadian Natural's (TSX: CNQ) (NYSE: CNQ) President, Scott Stauth, commented on the Company's first quarter results, "Canadian Natural is a world class company and during our 35 years of operations, we've delivered significant value, including recently reaching a position where, commencing in... Keep Reading...
Pine Cliff Energy Ltd. Announces Appointment of Officers, Declares Monthly Dividend for May 31, 2024 and First Quarter 2024 Webcast Details

Pine Cliff Energy Ltd. Announces Appointment of Officers, Declares Monthly Dividend for May 31, 2024 and First Quarter 2024 Webcast Details

Pine Cliff Energy Ltd. (TSX: PNE) (OTCQX: PIFYF) ("Pine Cliff" or the "Company") is pleased to announce the appointments of Mr. Daniel Keenan P. Eng to the position of Vice President Exploitation and Mr. Austin Nieuwdorp CA, CPA to the position of Vice President Finance and Controller both... Keep Reading...
Seegnal (TSXV:SEGN)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...
Cardiologist wearing virtual reality glasses.

Top 3 Medical Device ETFs for Investors in 2026

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug Administration (FDA).Wearable medical devices and the use of artificial intelligence in medical... Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...

Interactive Chart

Latest Press Releases

Related News